Similar Search Results

Are Risk Aversion and Impatience Related to Cognitive Ability?

Dohmen, Thomas; Falk, Armin; Huffman, David; Sunde, Uwe - CESifo - 2009

This paper investigates whether risk aversion and impatience are correlated with cognitive ability. We conduct incentive compatible choice experiments measuring risk aversion, and impatience over an annual time horizon, for a representative sample of roughly 1,000 German adults. A measure of...

Persistent link: https://www.econbiz.de/10005000392

Money Matters - Evidence from a Large-Scale Randomized Field Experiment with Vouchers for Adult Training

Messer, Dolores; Wolter, Stefan C. - CESifo - 2009

This paper presents the results of a randomized experiment analyzing the use of vouchers for adult training. In 2006, 2,400 people were issued with a training voucher which they were entitled to use in payment for a training course of their choice. User behavior was compared with a control group...

Persistent link: https://www.econbiz.de/10005181564

Effects of Prenatal and Early Life Malnutrition: Evidence from the Greek Famine

Neelsen, Sven; Stratmann, Thomas - CESifo - 2010

This paper examines the long run education and labor market effects from early-life exposure to the Greek 1941-42 famine. Given the short duration of the famine, we can separately identify the famine effects for cohorts exposed in utero, during infancy and at one year of age. We find that...

Persistent link: https://www.econbiz.de/10008583697

Effects of Adult Education Vouchers on the Labor Market: Evidence from a Randomized Field Experiment

Schwerdt, Guido; Messer, Dolores; Woessmann, Ludger; … - CESifo - 2011

Lifelong learning is often promoted in ageing societies, but little is known about its returns or governments’ ability to advance it. This paper evaluates the effects of a large-scale randomized field experiment issuing vouchers for adult education in Switzerland. We find no significant...

Persistent link: https://www.econbiz.de/10008833939

Pharmaceutical Innovation, Longevity, and Medical Expenditure in Greece, 1995-2010

Lichtenberg, Frank - CESifo - 2015

Longitudinal, disease-level data are used to analyze the impact of pharmaceutical innovation on longevity (mean age at … pharmaceutical innovation increased mean age at death by 0.87 years (10.4 months)-—about 44% of the total increase in longevity … pharmaceutical innovation. The baseline estimate of the cost per life-year gained from pharmaceutical innovation in Greece is $17 …

Persistent link: https://www.econbiz.de/10011122677